Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This case series found that adding microneedling to conventional finasteride and minoxidil therapy for androgenetic alopecia improved new hair growth and patient satisfaction in poor responders.

This study optimized conditions for extracting saponins from Eclipta prostrata, achieving maximum yield with specific ethanol concentration, time, temperature, and liquid/solid ratio.

In this study, sows fed a diet with added biotin weaned more pigs per litter overall, though other reproductive and health metrics showed no improvement.

This study found that Merkel cell clusters require Frizzled6 signaling for their polarity information, while other hair follicle-associated structures align their orientation based on the hair follicle itself.

In this study, three pediatric patients with alopecia areata demonstrated hair regrowth after being treated with ustekinumab.

This review highlights the potential of microneedles for immunotherapy, emphasizing their ability to enhance immune responses and reduce side effects through precise and stimuli-responsive delivery, especially in tumor treatment, while also noting the limitations and areas for improvement in current systems.

This study suggests that increased T cell blastogenesis may predict a positive response to topical 5% minoxidil treatment in patients with severe alopecia areata.

This study suggests that oral tofacitinib may be an effective treatment for beard regrowth in men with alopecia areata of the beard, with a strong correlation observed between beard and scalp hair regrowth.

This study found that among patients with alopecia areata treated with the JAK inhibitor tofacitinib, 34% achieved complete regrowth of eyebrows and 39% achieved complete regrowth of eyelashes, highlighting differences in treatment responses across hair-bearing sites.

This study found that selecting Angus cattle for early puberty reduced their prolactin levels, which may indicate a response to changing day length.

This response article concurs with Dr. Lipner's critique that biotin supplementation is largely unsupported for routine use in dermatological conditions, with evidence mostly limited to case reports.

Low-dose oral minoxidil combined with topical minoxidil improves hair density in breast cancer patients but may cause excess hair growth.

In this observational study, dutasteride treatment was associated with statistically significant stabilization of frontal fibrosing alopecia compared to other systemic therapies, with a dose-dependent effect observed across the frontal and bilateral temporal hairlines.

The authors reported that certain cosmetic procedures can lead to secondary alopecia, and suggested dermatologists play a crucial role in managing these complications and raising awareness about potential adverse effects.

Combining scalp photos with hair density and caliber measurements gives a more accurate assessment of hair loss.

This article discusses various limitations of direct-to-consumer teledermatology platforms, highlighting concerns regarding ethical issues, financial conflicts of interest, and challenges in providing comprehensive patient care compared to traditional in-person consultations.

This letter discusses the variability in platelet-rich plasma preparation for androgenetic alopecia treatment and highlights that different methods yield varied platelet concentrations but not significant differences in growth factor secretion per platelet.

This commentary highlights the debate on the role of inflammation and fibrosis in androgenetic alopecia, contrasting various studies' findings without reporting new results.

This study found that vitamin D levels in children with autoimmune alopecia were often below optimal, but did not suggest a need for extra vitamin D screening beyond standard practices.

This overview details the Dermatologic Surgery journal's extensive coverage of dermatologic surgery topics, including cosmetic and reconstructive procedures, but it reports no new research findings.

This article introduces the authors and acknowledges a disclosed conflict of interest without reporting any new clinical findings.

In this article, the author reports a case where hemiballismus was almost completely suppressed within 48 hours of starting haloperidol therapy, suggesting a therapeutic response to the drug.

This abstract does not report research results but acknowledges feedback concerning adherence to inclusion criteria from a prior study on the Ottawa rule by Perry et al., as shared in their CT-based clinical research.

Results are not reported in this response to a letter about the authors' recent meta-analysis.

Hair diameter diversity could improve androgenetic alopecia assessment and treatment planning.

Estrogen is not recommended for menopausal hair loss due to insufficient evidence.

Bicalutamide may take longer to work for female hair loss, and higher doses might be needed.

The reported treatment depths were likely incorrect and could risk patient safety.